We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Ophthalmology

Ophthalmology

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Distinct Molecular and Clinical Profiles of USH2A-Associated Retinitis Pigmentosa in Korean Patients: Implications for Targeted Therapy
newsophthalmologyretinitis pigmentosa

Distinct Molecular and Clinical Profiles of USH2A-Associated Retinitis Pigmentosa in Korean Patients: Implications for Targeted Therapy

By MedXY|Sep 19, 2026

This study elucidates the unique East Asian-specific genetic variants and clinical progression of USH2A-associated retinitis pigmentosa in Koreans, highlighting the potential for exon 13-targeted treatments.

Cystoid Macular Edema Following Cultured Human Corneal Endothelial Cell Injection: Incidence, Risk Factors, and Visual Prognosis
Clinical UpdatesVisual OutcomesCystoid Macular Edema

Cystoid Macular Edema Following Cultured Human Corneal Endothelial Cell Injection: Incidence, Risk Factors, and Visual Prognosis

By MedXY|Sep 19, 2026

This review synthesizes current evidence on the frequency and risk factors of cystoid macular edema (CME) after cultured human corneal endothelial cell (cHCEC) injection, highlighting prostaglandin analog use as a key associated factor and

One-Year Outcomes of WaveLight Plus InnovEyes Ray-Tracing-Guided LASIK: Precision Refractive Correction for Myopia and Myopic Astigmatism
newsLASIKrefractive surgery

One-Year Outcomes of WaveLight Plus InnovEyes Ray-Tracing-Guided LASIK: Precision Refractive Correction for Myopia and Myopic Astigmatism

By MedXY|Sep 18, 2026

This prospective study demonstrates that WaveLight Plus InnovEyes ray-tracing-guided LASIK achieves excellent safety, efficacy, and astigmatic correction precision in treating myopia and myopic astigmatism over one year.

Fenofibrate Use and Reduced Risk of Sight-Threatening Diabetic Retinopathy in Type 2 Diabetes: Insights from UK Real-World Data
Diabetes & Endocrinologyretinopathy đái tháo đườngtype 2 diabetes

Fenofibrate Use and Reduced Risk of Sight-Threatening Diabetic Retinopathy in Type 2 Diabetes: Insights from UK Real-World Data

By MedXY|Sep 18, 2026

Fenofibrate use in type 2 diabetes patients is associated with a significant reduction in the risk of sight-threatening diabetic retinopathy compared to statins, based on UK primary care data over 12 years.

Two-Year Outcomes of Intravitreal Pegcetacoplan in Managing Geographic Atrophy: Real-World Clinical Experience
newsIntravitreal Therapypegcetacoplan

Two-Year Outcomes of Intravitreal Pegcetacoplan in Managing Geographic Atrophy: Real-World Clinical Experience

By MedXY|Sep 17, 2026

Intravitreal pegcetacoplan significantly slowed geographic atrophy progression by 41% over two years, maintaining efficacy in clinical practice for AMD patients, with stable visual acuity decline and manageable safety.

Long-Term Visual Field Outcomes in Eyes with Failed Trabeculectomy: Evaluating Repeat Trabeculectomy versus Ahmed Glaucoma Valve Implantation
newsvisual field progressionÁp lực nội nhãn

Long-Term Visual Field Outcomes in Eyes with Failed Trabeculectomy: Evaluating Repeat Trabeculectomy versus Ahmed Glaucoma Valve Implantation

By MedXY|Sep 17, 2026

This retrospective cohort study compares visual field progression after repeat trabeculectomy versus Ahmed glaucoma valve implantation in eyes with prior trabeculectomy failure, revealing similar postoperative visual outcomes but greater in

Stratifying Risk for Further Retinal Intervention After Laser Retinopexy: The Impact of Cumulative Clinical Factors
newsvitreous hemorrhagerisk stratification

Stratifying Risk for Further Retinal Intervention After Laser Retinopexy: The Impact of Cumulative Clinical Factors

By MedXY|Sep 15, 2026

A novel, cumulative risk factor approach identifies patients at increased risk for additional retinal intervention after laser retinopexy for retinal tears, improving surveillance and management strategies.

Common Anti-Inflammatory Drugs Linked to Lower Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes
Diabetes & EndocrinologyAnti-inflammatory Drugsretinopathy đái tháo đường

Common Anti-Inflammatory Drugs Linked to Lower Risk of Vision-Threatening Diabetic Retinopathy in Type 2 Diabetes

By MedXY|Sep 15, 2026

A large retrospective cohort study suggests that cetirizine, ibuprofen, and prednisone use in adults with type 2 diabetes is associated with significantly reduced incidence of diabetic macular edema and proliferative diabetic retinopathy, h

Evolving Microbial Landscape and Clinical Profiles in Postcataract Endophthalmitis: Insights from a 23-Year Retrospective Cohort Study
newsclinical presentationmicrobial spectrum

Evolving Microbial Landscape and Clinical Profiles in Postcataract Endophthalmitis: Insights from a 23-Year Retrospective Cohort Study

By MedXY|Sep 13, 2026

This study reveals significant shifts in the bacterial spectrum, antimicrobial resistance, and clinical presentation of acute postcataract endophthalmitis over 23 years, underscoring the need for updated surveillance and tailored treatment

Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1
newscase reportdiagnosis

Widening the Spectrum of Disease Expression due to Heterozygous Variants in EFEMP1

By MedXY|Sep 13, 2026

A case series delineating a novel EFEMP1 variant, p.Arg140Trp, associated with late-onset peripheral retinal degeneration distinct from classic DHRD/ML, highlighting rod dysfunction precedes structural changes.

Why Metrics Matter in Thyroid Eye Disease: Exploring the Innovate TED Initiative
Diabetes & EndocrinologyClinical MetricsInnovate TED Initiative

Why Metrics Matter in Thyroid Eye Disease: Exploring the Innovate TED Initiative

By MedXY|Sep 13, 2026

This article examines the critical need for refined clinical metrics in thyroid eye disease (TED) to better evaluate new targeted therapies, highlighting the Innovate TED Initiative’s efforts to develop and validate comprehensive outcome me

Differential Impact of Reticular Pseudodrusen Subtypes on Retinal Sensitivity in Intermediate Age-Related Macular Degeneration
newsmicroperimetryretinal sensitivity

Differential Impact of Reticular Pseudodrusen Subtypes on Retinal Sensitivity in Intermediate Age-Related Macular Degeneration

By MedXY|Sep 12, 2026

This study elucidates how ribbon-type reticular pseudodrusen, especially when coexisting with soft drusen, significantly impair retinal sensitivity in intermediate AMD, highlighting the importance of lesion phenotype in functional risk asse

Unveiling Dupilumab-Associated Ocular Surface Disease in Atopic Dermatitis: Insights from a Large Prospective BioDay Cohort
Dermatologyatopic dermatitisdupilumab

Unveiling Dupilumab-Associated Ocular Surface Disease in Atopic Dermatitis: Insights from a Large Prospective BioDay Cohort

By MedXY|Sep 12, 2026

This study reveals that 30.7% of atopic dermatitis patients treated with dupilumab develop ocular surface disease, despite prevalent ocular symptoms at baseline and increased ophthalmic treatment during therapy, linked to reduced conjunctiv

Satralizumab Demonstrates Promising Efficacy and Safety in Treating Thyroid Eye Disease: Insights from Phase 3 SatraGO-1 and SatraGO-2 Trials
Diabetes & EndocrinologyThyroid Eye DiseaseSatralizumab

Satralizumab Demonstrates Promising Efficacy and Safety in Treating Thyroid Eye Disease: Insights from Phase 3 SatraGO-1 and SatraGO-2 Trials

By MedXY|Sep 12, 2026

Phase 3 trials show satralizumab significantly improves proptosis, inflammation, and diplopia in thyroid eye disease with a favorable safety profile, marking a new therapeutic option targeting the IL-6 receptor pathway.

Real-World Eligibility of Diabetic Macular Edema Patients for Anti-VEGF Trials: Implications for Clinical Practice and Health Equity
Diabetes & Endocrinologyreal‑world evidencehealth disparities

Real-World Eligibility of Diabetic Macular Edema Patients for Anti-VEGF Trials: Implications for Clinical Practice and Health Equity

By MedXY|Sep 11, 2026

A significant proportion of real-world diabetic macular edema patients are excluded from clinical trials of anti-VEGF therapy due to stringent systemic criteria, disproportionately affecting racial minorities. This study highlights the need

Cumulative Atopic Disease Burden and Keratoconus: Insights from Large-Scale Cross-Sectional and Longitudinal Analyses
Clinical Updatesepidemiologykeratoconus

Cumulative Atopic Disease Burden and Keratoconus: Insights from Large-Scale Cross-Sectional and Longitudinal Analyses

By MedXY|Sep 9, 2026

This review synthesizes evidence linking cumulative atopic diseases—including asthma, atopic dermatitis, and allergic rhinitis—to keratoconus risk, highlighting a dose-dependent association and the role of healthcare utilization in case asc

Sex-Specific Associations Between Adiposity and Dry Eye Disease: Insights from a Large UK Biobank Study
Diabetes & Endocrinologydry eye diseaseSex Differences

Sex-Specific Associations Between Adiposity and Dry Eye Disease: Insights from a Large UK Biobank Study

By MedXY|Sep 9, 2026

Central obesity in women and high overall body fat in men are linked to increased odds of dry eye disease, with distinct metabolic pathways implicated, based on a retrospective analysis of over 480,000 UK Biobank participants.

Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics
Clinical Updatesvisual fieldglaucoma

Event-Based Progression Detection in Glaucoma: Integrating OCT, OCT Angiography, and Visual Field Metrics

By MedXY|Sep 9, 2026

This review synthesizes recent evidence on event-based progression detection in glaucoma, highlighting that OCTA vessel density may identify progression earlier than structural OCT or visual field testing, with important implications for cl

Longitudinal Trajectories of 3-Dimensional Eye Shape and Pathological Sequelae in High Myopia: Implications for Personalized Surveillance
Clinical UpdatesMRIhigh myopia

Longitudinal Trajectories of 3-Dimensional Eye Shape and Pathological Sequelae in High Myopia: Implications for Personalized Surveillance

By MedXY|Sep 9, 2026

This review synthesizes longitudinal evidence on 3D eye shape remodeling in high myopia, linking distinct morphologic trajectories to sight-threatening outcomes and supporting individualized risk stratification beyond axial length alone.

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: Insights from the TEASE-1 Randomized Clinical Trial
Clinical Updatesrandomized clinical trialStargardt disease

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: Insights from the TEASE-1 Randomized Clinical Trial

By MedXY|Sep 7, 2026

This review synthesizes evidence from the TEASE-1 trial and related studies on gildeuretinol acetate, highlighting its safety profile and modest efficacy in slowing retinal atrophic lesion growth in Stargardt disease over 24 months.

1 / 12
123…12
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities

Browse by specialty

Open language-specific specialty feeds and department pages.

news6629 articlesCardiology1375 articlesClinical Updates1288 articlesOncology1139 articlesDiabetes & Endocrinology842 articlesNeurology820 articlesPublic Health595 articlesGastroenterology572 articles
Hematology-Oncology
487 articles
Pediatrics484 articles
Internal Medicine444 articles